Diego Ripamonti - Concepedia

Author

Diego Ripamonti

Azienda Ospedaliero Universitaria Ospedali Riuniti ORCID

Also Known As

D Ripamonti, D. Ripamonti, Diego Ripamonti, G Quinzan, Marco Froldi, Marco Ranucci, Maurizio Sanarico, Patrizia Zucchi, Ripamonti Diego, Ripamonti, Diego

125

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliero Universitaria Ospedali Riuniti Ospedale Papa Giovanni XXIII University of Brescia University of Bergamo Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

About

Diego Ripamonti is an author at Azienda Ospedaliero Universitaria Ospedali Riuniti specializing in medicine, hiv, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	478
2	Public Health	5	5	295
3	Health Sciences	2	2	59
4	Allergy	1	1	170
5	Biostatistics	1	1	18

Diego Ripamonti

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Chiara Fallerini, Sergio Daga, Stefania Mantovani, eLife	2021	207
IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study Giuseppe Gritti, Federico Raimondi, Diego Ripamonti, Clinical ImmunologyInflammatory Lung DiseaseLung InflammationImmunodeficienciesImmunology	2020	170
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells Franco Maggiolo, Diego Ripamonti, Gianpietro Gregis, AIDS	2004	123
Severe Hepatotoxicity During Combination Antiretroviral Treatment: Incidence, Liver Histology, and Outcome Massimo Puoti, Carlo Torti, Diego Ripamonti, JAIDS Journal of Acquired Immune Deficiency Syndromes	2003	114
Simpler Regimens May Enhance Adherence to Antiretrovirals in HIV-Infected Patients Franco Maggiolo, Diego Ripamonti, Claudio Arici, HIV Clinical Trials	2002	102
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer Diego Ripamonti, Dario Cattaneo, Franco Maggiolo, AIDS	2007	99
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients Franco Maggiolo, Roberto Gulminetti, Layla Pagnucco, BMC Infectious Diseases	2017	88
Factors associated with the failure of HIV-positive persons to return for scheduled medical visits Claudio Arici, Diego Ripamonti, Franco Maggiolo, HIV Clinical Trials	2002	76
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy Carlo Torti, Mattia Prosperi, Davide Motta, Clinical Microbiology and Infection Primary ImmunodeficiencyHiv/aids CounsellingCd4+ T-cell CountTreatment And PreventionCd4+/cd8+ T-cell Ratio	2011	69
Once-A-Day Therapy for HIV Infection: A Controlled, Randomized Study in Antiretroviral-Naive HIV-1-Infected Patients Franco Maggiolo, Diego Ripamonti, Gianpietro Gregis, Antiviral Therapy	2003	66

Page 1